Novartis AG (Novartis AG) Other Net Income (Loss) : $6,092 Mil (TTM As of Mar. 2024)

View and export this data going back to 1996. Start your Free Trial

What is Novartis AG Other Net Income (Loss)?

Novartis AG's Other Net Income (Loss) for the three months ended in Mar. 2024 was $0 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2024 was $6,092 Mil.

Novartis AG's quarterly Other Net Income (Loss) increased from Sep. 2023 ($250 Mil) to Dec. 2023 ($5,842 Mil) but then declined from Dec. 2023 ($5,842 Mil) to Mar. 2024 ($0 Mil).

Novartis AG's annual Other Net Income (Loss) declined from Dec. 2021 ($1,113 Mil) to Dec. 2022 ($906 Mil) but then increased from Dec. 2022 ($906 Mil) to Dec. 2023 ($6,282 Mil).

Novartis AG Other Net Income (Loss) Historical Data

The historical data trend for Novartis AG's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novartis AG Other Net Income (Loss) Chart

Novartis AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Net Income (Loss)

Get a 7-Day Free Trial

4,590.00

1,113.00

906.00

6,282.00

Novartis AG Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Net Income (Loss)	Get a 7-Day Free Trial															144.00	-	250.00	5,842.00	-

Novartis AG Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $6,092 Mil.

Novartis AG Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Novartis AG's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Novartis AG (Novartis AG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Novartis AG (OTCPK:NVSEF) » Definitions » Other Net Income (Loss)

Comparable Companies

Traded in Other Exchanges

NVS:USA NVS N:Mexico NOVNz:UK 0QLR:UK NOTA:Germany NOTA:Germany NOVNEE:Switzerland NOVN:Switzerland N1VS34:Brazil NVS:Argentina

Address

Lichtstrasse 35, Basel, CHE, 4056

Website

https://www.novartis.com

Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.